Myriad Genetics Inc.

NASDAQ: MYGN · Real-Time Price · USD
5.72
0.01 (0.18%)
At close: Aug 18, 2025, 3:59 PM
5.75
0.51%
After-hours: Aug 18, 2025, 05:35 PM EDT

Myriad Genetics Revenue

Myriad Genetics reported an annual revenue of $837.6M, reflecting a 11.21% growth. For the quarter ending June 30, 2025, Myriad Genetics generated $213.1M in revenue.
Revenue (ttm)
837.6M
Revenue Growth
11.21%
Price / Sales Ratio
1.48
Revenue / Employee
310.22K
Employees
2,700
Market Cap
532.22M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 837.6M +11.21%
Dec 31, 2023 753.2M +11.03%
Dec 31, 2022 678.4M -1.77%
Dec 31, 2021 690.6M +23.99%
Dec 31, 2020 557M -12.78%
Jun 30, 2020 638.6M -24.97%
Jun 30, 2019 851.1M +10.16%
Jun 30, 2018 772.6M +0.16%
Jun 30, 2017 771.4M +2.33%
Jun 30, 2016 753.8M +4.25%
Jun 30, 2015 723.1M -7.08%
Jun 30, 2014 778.22M +26.92%
Jun 30, 2013 613.16M +23.62%
Jun 30, 2012 496M +23.36%
Jun 30, 2011 402.08M +10.87%
Jun 30, 2010 362.65M +11.06%
Jun 30, 2009 326.53M -2.13%
Jun 30, 2008 333.63M +112.33%
Jun 30, 2007 157.13M +37.49%
Jun 30, 2006 114.28M +38.68%
Jun 30, 2005 82.41M +45.47%
Jun 30, 2004 56.65M -11.93%
Jun 30, 2003 64.32M +19.47%
Jun 30, 2002 53.84M +19.21%
Jun 30, 2001 45.16M +32.78%
Jun 30, 2000 34.01M +34.44%
Jun 30, 1999 25.3M +9.05%
Jun 30, 1998 23.2M +52.63%
Jun 30, 1997 15.2M +130.30%
Jun 30, 1996 6.6M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.